regulation of epithelial syndecan 1 expression by inflammatory cytokines l.
Download
Skip this Video
Loading SlideShow in 5 Seconds..
Regulation of epithelial syndecan-1 expression by inflammatory cytokines PowerPoint Presentation
Download Presentation
Regulation of epithelial syndecan-1 expression by inflammatory cytokines

Loading in 2 Seconds...

play fullscreen
1 / 27

Regulation of epithelial syndecan-1 expression by inflammatory cytokines - PowerPoint PPT Presentation


  • 499 Views
  • Uploaded on

Regulation of epithelial syndecan-1 expression by inflammatory cytokines. Richard M. Day, Tracey J. Mitchell, Stella C. Knight, Alastair Forbes Cytokine 21 (2003) 224–233. Introduction. Inflammatory bowel disease (IBD).

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'Regulation of epithelial syndecan-1 expression by inflammatory cytokines' - arleen


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
regulation of epithelial syndecan 1 expression by inflammatory cytokines

Regulation of epithelial syndecan-1 expression by inflammatory cytokines

Richard M. Day, Tracey J. Mitchell, Stella C. Knight, Alastair Forbes

Cytokine 21 (2003) 224–233

inflammatory bowel disease ibd
Inflammatory bowel disease (IBD)

Inflammatory bowel disease (IBD) refers to the condition that results when cells involved in inflammation and immune response are called into the lining of the GI tract.

IBD is characterized by chronic intestinal inflammation that results in clinical symptoms such as diarrhea, bleeding, abdominal pain, fever, joint pain, and weight loss.

Dysregulation of epithelial glycosaminoglycans (GAGs) occurs in IBD

Syndecans are a class of heparan sulphate proteoglycans that mediate both cell adhesion and growth factor binding via GAG side chains.

syndecan 1
Syndecan-1

Syndecan-1(CD138)

The best characterized of the four syndeacan core proteins binding to variety of components of extracellular matrix, including collagen type1 ,3,5 and fibronectin.

Syndecan-1 may regulate ligand-dependent activation of cell surface growth factor at two dimernsional surface of plasma membrane

Fibroblast growth factor(bFGF), hepatocyte growth factor,platelet-derived growth factor,vascular endothelial growth factor,and etc.

slide6

Mucosal cytokine may regulate epithelial cell function.

Reduced expression of syndecan-1 observed in IBD results from the increased presence of inflammatory cytokines.

slide7

Cell culture

      • Human colorectal carcinoma epithelial cell lines HT29/219 and T84
  • Cytotoxicity assay
      • The cytokine effects of TNF-a, IL-1b and IL-6.
  • Flow cytometry analysis
      • Epithelial cell surface syndecan-1 expression analysis
  • Co-culture with peripheral blood mononuclear cells
      • Co-culture of PBMC and epithelial (HT29) cell were stimulated with 20 ng/ml PMA and 2mM ionomycin for 24hr.
      • PMA phorbol 12-mryristate 13-acetate
slide8

Detection of soluble syndecan-1By ELISA

Immunocytochemistry

RNA extraction and amplification by reverse transcription-polymerase chain reaction

Statistical analysis

slide10

Fig. 1

unstimulated

5 ng/ml TNF-a

75 ng/ml TNF-a

IgG1 isotype control

slide11

IL-6

TNF-a

IL-1b

TNF-a

B,C,D HT29 cell

E T84 cell

slide12

Cell variability --- ApoAlert cytotoxicity assay

Above 86% for all concentrations of cytokine studied.

slide13

Fig. 2A

HT29 cell treated with 5 ng/ml TNF-a for the various time

slide15

Fig. 3

HT29 cell treated with TNF-a, IL-1b and IL-6 for 24h

Syndecan-1 expression reduced to 49.7%

Syndecan-1 expression reduced to 64.3%

slide16

Fig. 4

Increase 69.3%

Cytokine stimulation induced syndecan-1 shedding from the cell surface

Increase 8.1%

Increase 17.1%

slide18

Fig. 6

Co-culture HT29 cell and PBMC

PBMC endogenous inflammatory cytokine

PMA increase syndecan-1 suppression

slide20

Epithelial expression of syndecan-1 is down-regulated in the mucosa of the patients with IBD

    • Epithelium overlying inflamed mucosa and reparative epithelium

Wound repair

other model without inflammation

(up-regulation)

The expression of

syndecan-1

Increased syndecan-1 expression during wound repair is thought to facilitate growth factor binding and wound healing.

The reduced expression in IBD maybe related to the presence of inflammatory cytokines in mucosa.

slide21

Does-dependent down-regulate syndecan-1 mRNA

Stable expression of syndecan-1

TNF-a, IL-1b and IL6 stimulate

Reduced Syndecan-1 expression

HT29 cell

T84 cell

IL-6 to cause a reduction of syndecan-1 expression in murine B-lymphoid cells  cell-type specific

slide22

Epithelial cell adhesion molecules

Syndecan-1, E-cadherin

Inflammatory cytokine ex. TNF-a IL-1

dysregulation

Expression of E-cadherin is dependent on syndecan-1 expression and vice versa.

Cytokine induce loss of cell-adhesion through reduced syndecan-1 and/or E-caderine destablizes the epithelial barrier.

Increase intestinal permeability in IBD

slide23

Shedding of syndeacan-1 ectodomain into the culture medium of HT29 cell monolayers was significantly increase following the addition of TNF-a .

The increase syndecan-1, shedding following stimulation correlated with the loss of membrane syndecan-1 expression

Some syndecan-1 detected may also have been released as the intact proteoglycan from dead cell

slide24

Release inflammatory cytokine

block

PBMC

Reduced syndecan-1 expression

Co-culture

HT29 cell

Increased ICAM-1 expression

HT29 cell

+ TNF-a and IL-1b

The loss of GAG expression in p’t with IBD is associated with increased density of TNF-a

slide25

This study demonstrates dysregulation of epithelial syndecan-1 expression by inflammatory cytokines and may have implications for mucosal ulcer healing.

slide26

Inflammatory bowel disease refers to the condition that results when cells involved in inflammation and immune response are called into the lining of the GI tract. This infiltration thickens the bowel lining and interferes with absorption and motility (the ability of the bowel to contract and move food). With abnormal ability to contract and abnormal ability to absorb, the bowel’s function is disrupted. Chronic vomiting results if the infiltration is in the stomach or higher areas of the small intestine. A watery diarrhea with weight loss results if the infiltration is in the lower small intestine. A mucous diarrhea with fresh blood (colitis)  results if the infiltration occurs in the large intestine. Of course, the entire tract from top to bottom may be involved. Many people confuse Inflammatory Bowel Disease with “Irritable Bowel Syndrome,” a stress-related diarrhea problem. Treatment for “IBS” is aimed at stress; it is a completely different condition from “IBD.”

slide27

These symptoms can range from mild to severe, and may gradually and subtly develop from an initial minor discomfort, or may present themselves suddenly with acute intensity.